MDRX Stock Recent News

CHICAGO--(BUSINESS WIRE)--Veradigm® (OTCMKTS: MDRX), a leading provider of healthcare data and technology solutions, announced today that Black Book Research, a healthcare-centric market research and public opinion research and consulting company, rated Veradigm Payer Analytics the overall number one provider of payer analytics solutions for health plans. Veradigm has achieved this ranking for the second year in a row, also earning top marks in 2024. Veradigm Payer Analytics earned top category.

CHICAGO--(BUSINESS WIRE)--Veradigm® (OTCMKTS: MDRX), a leading provider of healthcare data and technology solutions, announced today that Syracuse Orthopedic Specialists has selected elements from the Veradigm solution suite, Veradigm Revenue Cycle Services and Coding Services designed to support growth, improve cash flow and reduce costs. Syracuse Orthopedic Specialists, located near Syracuse, NY, provides total orthopedic care to the surrounding regions, and is currently utilizing Veradigm Re.

Veradigm Inc. (OTC:MDRX) Investor Update Call March 19, 2025 8:00 AM ET Company Participants Jenny Gelinas - VP, IR Tom Langan - Interim CEO Lee Westerfield - Interim CFO Conference Call Participants Charles Rhyee - TD Cowen Jeff Garro - Stephens George Hill - Deutsche Bank Operator Greetings, and welcome to the Veradigm Investor Update Call. At this time, all participants are in a listen-only mode.

CHICAGO--(BUSINESS WIRE)--Veradigm® (OTCMKTS: MDRX), a leading provider of healthcare data and technology solutions, provided updates on financial information for fiscal 2023 and 2024 and an outlook for fiscal 2025. “We remain confident in Veradigm's business model and our value proposition,” said Tom Langan, Interim Chief Executive Officer. “We believe our core business is sound. We remain focused on remediating our material weaknesses and other internal control deficiencies, becoming current.

CHICAGO--(BUSINESS WIRE)--Veradigm® (OTCMKTS: MDRX), a leading provider of healthcare data and technology solutions, announced today that it filed its comprehensive Annual Report on Form 10-K for the year ended December 31, 2022, which also contains certain restated financial statements for periods in fiscal year 2022, 2021 and 2020 (the “2022 Form 10-K”), with the Securities and Exchange Commission (“SEC”). “This filing represents an important step toward regaining compliance with our financia.

CHICAGO--(BUSINESS WIRE)--Veradigm® (OTCMKTS: MDRX), a leading provider of healthcare data and technology solutions, announced today that management plans to provide a financial update after the close of regular stock market hours on March 18, 2025. Veradigm management plans to host an investor conference call and webcast to discuss the Company's update at 8:00 a.m. Eastern Time on March 19, 2025. Update Call Details Veradigm plans to distribute an announcement promptly after the close of regul.

CHICAGO--(BUSINESS WIRE)-- #healthIT--Veradigm® (OTCMKTS: MDRX), a leading provider of healthcare data and technology solutions, announced today that over 3,500 healthcare practices across the United States are now receiving gaps-in-care alerts from several national and regional health plans directly in their electronic health records (EHRs) via the Veradigm Payer Insights solution. With the gaps-in-care alerts directly in providers' day-to-day workflow through their EHRs, health plans can significantly re.

Veradigm will add four new directors to its board in an agreement with investor Kent Lake Capital, the healthcare technology company said on Thursday just weeks after concluding a strategic review.

CHICAGO--(BUSINESS WIRE)-- #healthIT--Veradigm® (OTCMKTS: MDRX) (“Veradigm” or the “Company”), a leading provider of healthcare data and technology solutions, announced today it has entered into a Cooperation Agreement (the “Agreement”) with Kent Lake PR LLC (“Kent Lake”). The Agreement aligns with the Board's request for input from shareholders regarding board composition on January 30, 2025, and a desire to conduct an orderly refreshment of the Board following the conclusion of the exploration of strateg.

CHICAGO--(BUSINESS WIRE)-- #healthIT--Veradigm® (OTCMKTS: MDRX), a leading provider of healthcare data and technology solutions, today announced that its Board of Directors (the “Board”) has approved an amendment to extend the Company's existing Stockholder Rights Plan (the “Rights Plan”). The Rights Plan, adopted on February 26, 2024, was due to expire on February 26, 2025. Under the terms of the amendment to the Rights Plan, the scheduled expiration date of the Rights Plan has been extended to August 20,.